GLPG-1205

N/A

Report date: 2026/03/10 20:00:16
NME

Base Information

Drug NameGLPG-1205
Drug Alias NameGLPG-1205
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionG-protein coupled receptor 84 antagonists
TargetsG-protein coupled receptor 84
Therapy Area/IndicationsIdiopathic Pulmonary FibrosisColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[17] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGalapagos Nv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGilead Sciences IncGalapagos Nv
Active IndicationsN/A
Inactive IndicationsIdiopathic Pulmonary FibrosisColitis, Ulcerative

Other Information

ATC CodeN/A
Related LinksN/A